The global anxiety and depression treatment market had a valuation of $17,770.9 million in 2020 and it is predicted to generate a revenue of $24,467.7 million by 2030. According to the estimates of the market research company, P&S Intelligence, the market will advance at a CAGR of 3.3% from 2021 to 2030. The key factors driving the advancement of the market are the surging geriatric population and the growing public awareness about mental disorders and their treatments around the world.
Browse detailed report on Anxiety and Depression Treatment Market Revenue Estimation and Forecast
In the U.S., the National Alliance on Mental Illness (NAMI), which is a mental health organization providing support, treatment, and education on mental illness, was set up in 1979. These initiatives and measures are massively propelling the demand for anxiety and depression products and treatment procedures all over the world. Depending on product type, the market is divided into devices and drugs. Between these, the drugs category held higher market share in the past.
This is attributed to the growing prevalence of depressive ailments, the rapidly declining financial stability of people, and the surging number of individuals participating in screening tests for mental diseases. Globally, the anxiety and depression treatment market is predicted to register the fastest growth in the Asia-Pacific (APAC) region in the upcoming years. This will be because of various factors such as the growing incidence of anxiety and depression in the region.
